Venous stent for Iliofemoral Vein Investigational clinical trial using Vesper DUO Venous Stent System©
The VIVID clinical trial is studying an investigational device called the Vesper DUO Venous Stent System that includes both the DUO HYBRID™ and DUO EXTEND™ stents. These new venous stents are intended to endure the unique forces and motion that happen in deep veins and are designed to reduce the symptoms associated with CVI. They are being studied to treat iliac and common femoral vein blockages with or without a history of a blood clot in the legs.
VIVID is a prospective, multi-center, single-arm, global IDE clinical trial evaluating the safety and efficacy of the Vesper DUO Venous Stent System in the treatment of iliofemoral occlusive disease.
Up to 160 subjects will be enrolled at up to 45 U.S. and International clinical sites.
This study is being led by co-principal investigators, Dr. Mahmood Razavi and Dr. Michael Lichtenberg and is currently recruiting adult patients with CVI in the United States, Germany, Ireland, Poland and United Kingdom.
Speak with your doctor to see if you qualify to participate in the VIVID clinical trial.
Contact us for information about Vesper Medical and the VIVID clinical study
* Required Field